SV Biotech Crossover Opportunities Fund LP
Form D Filings
Location
London, United Kingdom
Investment Fund Type
Venture Capital Fund
Industry Group
Pooled Investment Fund
Related People
SV BCO I GP LLP
,
SV Health Managers LLP
,
Houman Ashrafian
,
Kate Bingham
,
Nicola Trbovic
Entity Type
Limited Partnership
CIK
0001903934
13D/G Filings
1 filing
All SEC Filings
View on sec.gov
Date Filed
Security Types
Total Amount Sold
Total Offering
Amount Remaining
First Sale
Signed
Form
SEC Link
1/18/2022
Equity, Pooled Investment Fund
$135,180,000
$350,000,000
$214,820,000
12/31/2021
1/18/2022
D
000190393422000001